Close menu




March 15th, 2023 | 10:04 CET

Varta, Plug Power, Altech Advanced Materials: Only one share is currently convincing

  • Innovations
  • Technology
  • renewableenergies
  • Batteries
Photo credits: Nordex SE

In difficult stock market phases, real strength shows. Investors should therefore pay close attention at the moment. There is no doubt that exciting business models are emerging around the energy transition, for example. But who are the winners, and who are the losers? Today we take a look at Varta, Plug Power and Altech Advanced Materials. How are things looking in the supply chain? What is going on operationally, how does it look chart-wise, and what are the prospects? We can reveal that only one share is currently convincing on all three points.

time to read: 4 minutes | Author: Fabian Lorenz
ISIN: VARTA AG O.N. | DE000A0TGJ55 , PLUG POWER INC. DL-_01 | US72919P2020 , ALTECH ADV.MAT. NA O.N. | DE000A2LQUJ6

Table of contents:


    Altech: Things are currently going well

    Things are currently going well at Altech Advanced Materials AG. The Heidelberg-based company is working on a new standard for lithium-ion batteries. From a chart perspective, things are also looking really good. After the share tripled in value within a few days last fall, it has maintained a high level and can thus soon take off again. In order to continue research and expand battery production, Altech recently successfully placed a convertible bond with a volume of around EUR 3.5 million. In the current environment, this is quite remarkable. It also confirms investors' confidence in the technology of Altech and its joint venture partners.

    As a first step, Altech's newly developed coating technology is expected to help prevent the loss of battery capacity that has been common up to now. The Company is currently building a pilot plant in Saxony, Germany, to convince e-car manufacturers of the benefits of the batteries, for example.

    Altech's other plans are even more exciting: the production of solid-state batteries for energy storage - these will make a decisive contribution to the success of the energy transition in the future. The market volume is huge: Altech expects the market for grid storage to grow by around 28% annually in the coming decades, reaching a volume of USD 15.1 billion in 2027. Together with the Fraunhofer Institute for Ceramic Technologies and Systems, the Company is researching solid-state sodium-alumina batteries. These require neither lithium, graphite, copper, nor cobalt and are thus considered future-oriented. Fraunhofer estimates that the cost of producing the batteries, called CERENERGY, will be around 40% lower than lithium-ion batteries. They are also expected to be fire- and explosion-proof and have a service life of more than 15 years. The capacity of the first production line is already said to be 100 MWh p.a. Although Altech is "only" the junior partner in the joint venture with a share of 18.75%, this also has advantages. The risk is reduced, and the Company has to bear the smaller part of the investment. Otherwise, the market capitalization would likely not be below EUR 40 million but well into triple digits.

    Varta: Where are the price drivers?

    Varta has blown its entry into the battery market. Since the profit warning in the fall and the crash of the share from over EUR 60, the price has been bobbing between EUR 20 and EUR 30. Thus the share of the German battery icon has more or less degenerated into a gambler's stock.

    Operationally, there is currently little news to report. It has become very quiet around V4Drive as Varta's entry into the e-car battery segment. Most recently, the Company has put the energy storage area up front and jumped on the AI hype. As part of a research project, Varta wants to make its batteries more efficient with the help of artificial intelligence (AI). The aim is to optimize the available capacity and reduce the wear and tear on batteries. However, this is a lot of future talk and will hardly help the share in the foreseeable future. The project is expected to run until 2025.

    Plug Power: Figures down, outlook up

    The situation at Plug Power is also tricky at present, but the outlook appears better than at Varta. The American company had to publish several sales and profit warnings in 2022. In the end, sales were around EUR 701 million. Like other hydrogen companies such as Nel and ITM Power, Plug Power was plagued by supply chain problems. However, the outlook is positive. Sales are expected to rise to USD 1.4 billion in the current year. And the order intake also gives cause for hope. Most recently, Uniper placed an order. Plug Power is to build an electrolyzer to produce green hydrogen in the port of Rotterdam for the energy supplier. Production is to start in 2026 with a capacity of 100 MW. It is to be expanded to 500 MW by 2030.

    Plug Power needs to cut losses. Source: Plug Power Inc.

    But order intake has never been Plug Power's problem - instead, it is the implementation. Therefore, the chart is severely battered. In February, the security fell out of the sideways trend between USD 15 and 19. With the downward movement, the 50-day line was also undercut. Currently, the share can at least still hold above the support of USD 12 - but no more.


    Varta and Plug Power are not worth buying at the moment. The German battery producer has disappointed too often and lacks the price driver for the next 1 to 2 years. However, the price fluctuations are still high and interesting for traders. At Plug Power, investors invest in the breakthrough in hydrogen. Currently, companies around the world are investing heavily in technology. But Plug Power needs to increase sales more quickly and reduce losses significantly. At Altech, things are going well: the battery technologies seem promising, the stock chart looks good, and the successful capital measure shows investors have confidence.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may hold shares or other financial instruments of the aforementioned companies in the future or may bet on rising or falling prices and thus a conflict of interest may arise in the future. The Relevant Persons reserve the right to buy or sell shares or other financial instruments of the Company at any time (hereinafter each a "Transaction"). Transactions may, under certain circumstances, influence the respective price of the shares or other financial instruments of the Company.

    In addition, Apaton Finance GmbH is active in the context of the preparation and publication of the reporting in paid contractual relationships.

    For this reason, there is a concrete conflict of interest.

    The above information on existing conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on news.financial. These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user.

    The acquisition of financial instruments involves high risks, which can lead to the total loss of the invested capital. The information published by Apaton Finance GmbH and its authors is based on careful research. Nevertheless, no liability is assumed for financial losses or a content-related guarantee for the topicality, correctness, appropriateness and completeness of the content provided here. Please also note our Terms of use.


    Der Autor

    Fabian Lorenz

    For more than twenty years, the Cologne native has been intensively involved with the stock market, both professionally and privately. He is particularly passionate about national and international small and micro caps.

    About the author



    Related comments:

    Commented by Stefan Bode on September 2nd, 2026 | 07:10 CEST

    Between Renewed Interest Rate Fears, Technological Breakthroughs and Disruptive Competition – Vonovia, dynaCERT and Siemens Energy

    • Hydrogen
    • cleantech
    • RealEstate
    • Energy
    • Technology

    Rising bond yields and restrictive central bank policies are challenging established business models following years of low interest rates. While a real estate giant is grappling with the consequences of tighter monetary policy, a pioneer in clean mobility technology is striving to make the decisive leap from pilot projects to regional market leadership. At the same time, a visionary tech billionaire is causing unrest amongst industry leaders with ambitious expansion plans in the energy sector. Which players can hold their own in this dynamic environment, and where do sensitive share price setbacks loom?

    Read

    Commented by Fabian Lorenz on September 1st, 2026 | 07:45 CEST

    Potential Moderna-Style Share Surge? Takeover Candidates Evotec, Valneva and Vidac Pharma in Focus — Analysts Bullish

    • Biotechnology
    • Pharma
    • Innovations
    • Oncology

    Moderna has shaken up the biotech market with its breakthrough in the fight against skin cancer. Partner Merck has received somewhat less attention in the coverage, despite preparing for the eventual patent expiration of one of its blockbuster drugs. Other pharmaceutical companies will also need to replenish their pipelines in the coming years. As a result, the takeover merry-go-round is likely to pick up speed again, potentially electrifying investors. One hot candidate is Vidac Pharma. Recruitment for its Phase 2B trial into high-risk actinic keratosis, a precancerous skin condition, has been completed. The results could provide a catalyst for the stock. Valneva's share price has recently risen sharply. Could its partner Pfizer eventually make a move? Analysts are recommending the stock. And what about perennial takeover candidate Evotec? Shareholders and potential buyers are currently giving the share a wide berth. Yet there is a "Buy" recommendation on the table.

    Read

    Commented by Stefan Bode on September 1st, 2026 | 07:00 CEST

    Special Situations on the Stock Market: Three Stories, One Common Thread — Delivery Hero, Nemetschek, Zefiro Methane and Uber Technologies

    • methane
    • OrphanWells
    • AI
    • Software
    • Technology
    • Food

    Created and published on behalf of Zefiro Methane

    Takeover premiums, restructuring and infrastructure trends, as well as AI-driven shifts in market sentiment, can have a major short-term impact on share prices. Yet behind the headlines in the financial press, the fine print often determines where a stock goes next. Key factors include the time until a takeover is completed, regulatory approval and execution risks, cash flow quality and valuation relative to industry peers. These key factors explain why opportunities on the stock market are rarely "free". However, investors who understand how these dynamics work can better assess both the associated risks and the potential returns.

    Read